Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2Tumor-Agnostic 1Other solid neoplasm 1Lymphoid 1Gynecologic 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Advanced Breast Cancer 1

Interventions

Letrozole 31Fulvestrant 30Specimen Handling 28pembrolizumab 22ribociclib 20Magnetic Resonance Spectroscopy 19Trastuzumab 18Paclitaxel 18palbociclib 17Capecitabine 17Anastrozole 17exemestane 15abemaciclib 15Biopsy 15pertuzumab 14Tamoxifen 14Carboplatin 14trastuzumab deruxtecan 11Cyclophosphamide 10Taxes 8Radiotherapy 8Goserelin 8inavolisib 6giredestrant 6atezolizumab 6Standard of Care 6Nivolumab 6Gemcitabine 6Docetaxel 6Aromatase Inhibitors 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Itraconazole × Breast × 30 days × Clear all
NCT06710990 2026-06-04

Investigation of Drug-drug Interaction of Ritonavir and Itraconazole on the Pharmacokinetics of SHR-A1811 in Subjects With HER2-expressing Advanced Breast Cancer

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Completed
17 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡